Dr. Stephen Deacon

Chief Scientific Officer
Stephen Deacon

Steve joined Pharmanovia as the Chief Scientific Officer in June 2022, responsible for product innovation and development, medical and regulatory affairs and clinical development.

Steve spent 30 years developing medicines initially in an academic setting with a PhD in Clinical Endocrinology and University Lecturer in Human Physiology and Clinical Biochemistry before embarking on an industry career with SmithKline Beecham, Lundbeck, Ono Pharmaceuticals and Haoma Medica.  Most recently, he was Chief Development Officer and CEO of a clinical stage biotech.  His industry experience covers all aspects of clinical research and development (Phases I-IV) from product and clinical development strategies to global program/operational management of internal and outsourced teams.

Steve has published over 70 articles including 46 peer reviewed papers and has made over 50 conference presentations. He is a Fellow of the Royal Society for Biology and current member of the Drug Information Association (DIA).